Close this search box.

Pamela Stephenson to head commercial at Disc

ARTICLE | Management Tracks

Plus: Seres names Marella Thorell as CFO, and updates from Diakonos and NRx

By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst 

February 27, 2024 1:35 AM UTC

Pamela Stephenson became chief commercial officer of Disc Medicine Inc. (NASDAQ:IRON), a hematological disease company. Stephenson was CCO of Albireo Pharma Inc., where she led the launch of rare liver disease drug Bylvay odevixibat, and VP, global market access and value at Vertex Pharmaceuticals Inc. (NASDAQ:VRTX).

Microbiome therapeutics company Seres Therapeutics Inc. (NASDAQ:MCRB) hired Marella Thorell as EVP and CFO, effective March 25. Thorell was CFO at Evelo Biosciences Inc. (NASDAQ:EVLO) and will succeed David Arkowitz, who is retiring. …